The Journal of the American College of Cardiology: Clinical Electrophysiology has published an article investigating BioSig Technologies’ Pure EP system.
According to a company release, the publication highlights Pure EP’s broader dynamic range and sampling rate versus standard EP recording systems as well as the use of additional proprietary filtering and processing to improve recording of Purkinje potentials and other high-frequency signals in pre-clinical studies.
The researchers discussed Pure EP’s ability to detect and visualise high-frequency signals in the presence of larger waveforms as well as its capability to display the same channel with different processing options to highlight specific features while still displaying the original electrogram signal. According to the release, the authors state that these features may improve mapping and ablation outcomes in arrhythmias dependent upon the Purkinje network.
